Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) is projected to announce its earnings results before the market opens on Tuesday, March 18th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $10.53 million for the quarter.
Eton Pharmaceuticals Price Performance
Shares of NASDAQ ETON opened at $15.58 on Friday. Eton Pharmaceuticals has a 1 year low of $3.03 and a 1 year high of $18.41. The firm has a 50-day moving average of $15.33 and a 200 day moving average of $11.23. The stock has a market cap of $405.87 million, a P/E ratio of -70.82 and a beta of 1.37.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on ETON. Craig Hallum upped their price objective on shares of Eton Pharmaceuticals from $15.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, January 8th. B. Riley assumed coverage on shares of Eton Pharmaceuticals in a report on Friday, January 10th. They issued a “buy” rating and a $21.00 price target on the stock. Finally, HC Wainwright increased their price target on shares of Eton Pharmaceuticals from $17.00 to $33.00 and gave the stock a “buy” rating in a report on Thursday, January 23rd.
About Eton Pharmaceuticals
Eton Pharmaceuticals, Inc, a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1.
Further Reading
- Five stocks we like better than Eton Pharmaceuticals
- How to trade penny stocks: A step-by-step guide
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What Do S&P 500 Stocks Tell Investors About the Market?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- 3 Small Caps With Big Return Potential
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Eton Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eton Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.